MAGENTA THERAPEUTICSCS INC
MAGENTA THERAPEUTICSCS INC
Action · US55910K1088 · MGTA · A2JPD6 (XNMS)
Aperçu Indicateurs financiers
Pas de cours
n/a

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
- - - - 0,00 % 0,00 % -92,30 %

Profil de l'entreprise pour MAGENTA THERAPEUTICSCS INC Action

Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that cause acute myeloid leukemia and myelodysplastic syndromes, which is under Phase I/II clinical trial; CD45-antibody drug conjugate that targets HSCs and immune cells, which is in investigational new drug application enabling studies for potential use as a single-agent in autoimmune diseases and hematology-oncology transplants; and MGTA-145 that is in Phase II clinical trial for use in autologous and allogeneic transplants. The company also has a cell therapy program, E478, which is a small molecule aryl hydrocarbon receptor antagonist for stem cell-based gene therapy and genome editing. Magenta Therapeutics, Inc. has a research and clinical collaboration agreement with AVROBIO, Inc. for the treatment of lysosomal storage disorders; and Beam Therapeutics, Inc. to evaluate the potential utility of MGTA-117 for conditioning of patients with sickle cell disease and beta-thalassemia. The company was formerly known as HSCTCo Therapeutics, Inc. and changed its name to Magenta Therapeutics, Inc. in February 2016. Magenta Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Fonds investis

Les fonds suivants ont investi dans : MAGENTA THERAPEUTICSCS INC investi :

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millions
12,52
Part (%)
0,03 %

Données de l'entreprise

Nom MAGENTA THERAPEUTICSCS INC
Société Magenta Therapeutics, Inc.
Symbole MGTA
Site web https://www.magentatx.com
Marché d'origine XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A2JPD6
ISIN US55910K1088
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Stephen F. Mahoney J.D., MBA
Capitalisation boursière 42 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,1 T
Adresse 100 Technology Square, 02139 Cambridge
Date d'introduction en bourse 2018-06-21

Symboles boursiers

Nom Symbole
NASDAQ MGTA

Autres actions

Les investisseurs qui détiennent MAGENTA THERAPEUTICSCS INC ont également les actions suivantes dans leur portefeuille :
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Action
AMGEN INC
AMGEN INC Action
AUTODESK INC
AUTODESK INC Action
CINTAS CORP
CINTAS CORP Action
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
DWS INVEST CROCI US USD LC
DWS INVEST CROCI US USD LC Fonds
INTEL CORP
INTEL CORP Action
LYXOR EURO GOVERNMENT BOND 3-5Y (DR) UCITS ETF - ACC
LYXOR EURO GOVERNMENT BOND 3-5Y (DR) UCITS ETF - ACC ETF
MICROSOFT CORP
MICROSOFT CORP Action
OC OERLIKON 21/28
OC OERLIKON 21/28 Obligation
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Action
TITAN INTL INC
TITAN INTL INC Action
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025